Correlation Between Electra and Purple Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Electra and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Electra and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Electra and Purple Biotech, you can compare the effects of market volatilities on Electra and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Electra with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Electra and Purple Biotech.

Diversification Opportunities for Electra and Purple Biotech

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Electra and Purple is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Electra and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Electra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Electra are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Electra i.e., Electra and Purple Biotech go up and down completely randomly.

Pair Corralation between Electra and Purple Biotech

Assuming the 90 days trading horizon Electra is expected to generate 0.35 times more return on investment than Purple Biotech. However, Electra is 2.89 times less risky than Purple Biotech. It trades about 0.08 of its potential returns per unit of risk. Purple Biotech is currently generating about -0.12 per unit of risk. If you would invest  14,690,800  in Electra on September 2, 2024 and sell it today you would earn a total of  4,652,200  from holding Electra or generate 31.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Electra  vs.  Purple Biotech

 Performance 
       Timeline  
Electra 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Electra are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Electra sustained solid returns over the last few months and may actually be approaching a breakup point.
Purple Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Electra and Purple Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Electra and Purple Biotech

The main advantage of trading using opposite Electra and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Electra position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.
The idea behind Electra and Purple Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments